Wegovy has demonstrated impressive efficacy in multiple clinical trials, with the STEP 1 trial showing adults without diabetes who had obesity or were overweight lost an average of 14.9% of their body weight after 68 weeks of treatment
They work by killing the bacteria causing the infection
GLP-1 receptor agonism is the backbone of many successful anti-obesity and anti-diabetic medications
For type 2 diabetes, GLP-1 agonists reduce A1C by 1.0 to 2.5 percentage points and significantly lower cardiovascular event risk in people with established heart disease
But they caution, theres no research about how these drugs might affect a babys development, so they strongly recommend losing the weight, then getting off the medication for a while before trying to get pregnant
Beyond glycemic control, GLP-1 receptor agonists slow gastric emptying, prolonging the sensation of fullness after meals